Cargando…
MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
OBJECTIVES: Osteosarcoma (OS) is the most common bone cancer diagnosed in children and adolescents. Expression of APE1 is commonly increased in OS, and this is negatively correlated with a sensitivity to platinum and a favorable prognosis. However, the mechanism underlying high APE1 expression in OS...
Autores principales: | Liang, Wei, Li, Chongyi, Li, Mengxia, Wang, Dong, Zhong, Zhaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731985/ https://www.ncbi.nlm.nih.gov/pubmed/31564904 http://dx.doi.org/10.2147/OTT.S194800 |
Ejemplares similares
-
MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma
por: Liang, Wei, et al.
Publicado: (2017) -
Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020) -
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016) -
Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142
por: Zhang, Longqiang, et al.
Publicado: (2020) -
Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma
por: HONG, XIAO CHUN, et al.
Publicado: (2015)